Thought Leadership
A Federal Appeals Court Once Again Casts Doubt on "Skinny Labels" and Generic Drug Access
February 16, 2022
Ed Silverman
STAT

Axinn partner David Silverstein was quoted in the STAT article, "A Federal Appeals Court Once Again Casts Doubt on 'Skinny Labels' and Generic Drug Access."

Click here to access the article. A subscription is required.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.